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Objective: This study aimed to assess the survival and life quality evolution of patients subjected to surgical excision of oral and oropharyngeal squamous cell carcinoma. 
Material and Methods: Forty-seven patients treated at a Brazilian healthcare unit specialized 
in head and neck surgery between 2006 and 2007 were enrolled in the study. The gathering 
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of Life (UW-QOL) questionnaire previously and 1 year after the surgery. Comparative 
analysis used Poisson regression to assess factors associated with survival and a paired 
t-test to compare preoperative and 1-year postoperative QOL ratings. Results: 1 year after 
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UW-QOL again. The risk of death was associated with having regional metastasis previously 
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74.0 before surgery to 34.0 one year later. Anxiety was the only domain whose average 
rating increased (from 36.0 to 70.7). Conclusions: The prospective assessment of survival 
and quality of life may contribute to anticipate interventions aimed at reducing the incidence 
of functional limitations in patients with oral and oropharyngeal cancer.
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INTRODUCTION
“Quality of life” (QOL) is a construct increasingly 
used to assess health status and the impact of 
therapeutics in patients with different diseases. In 
1994, a panel of researchers from the World Health 
Organization proposed a unifying and transcultural 
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his or her position in life, within the cultural context 
and value system he or she lives in, and in relation 
to his or her goals, expectations, parameters and 
social relations”13.
QOL is a comprehensive, multidimensional 
concept, further specified as health-related 
quality of life (HRQOL) in assessments addressing 
treatment side effects, physical function and 
performance. For cancer patients, HRQOL is the 
+8X+,%" !"7TU"%1$%"+(,&*3&$224"),!,)+"% "%1,"X8)#,/"
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how they cope with treatment7. HRQOL is currently 
considered a powerful predictor of mortality and 
morbidity14.
For patients with head and neck (H&N) cancer, 
the self-oriented HRQOL evaluation is a useful aid 
to the assessment of therapeutic effectiveness, 
which otherwise would rely exclusively on endpoint 
results such as survival and tumor relapse. The 
assessment of HRQOL allows health professionals 
www.scielo.br/jaos
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to appraise the physical, mental and social 
impact of therapeutics, and improve their ability 
to anticipate the patient’s prognosis. Despite 
advances in diagnosis and treatment, oral and 
oropharyngeal tumor resection remains associated 
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essential domains of life. The importance of 
assessing the self-reported evaluation of functional 
status and well-being of these patients has been 
well documented in the literature6,7,12.
This study specifically aimed at describing 
the HRQOL evolution of patients with oral and 
oropharyngeal cancer 1 year after primary surgery 
for tumor resection, as a strategy to contribute to 
the planning of postoperative clinical follow-up.
MATERIAL AND METHODS
The study sample comprised patients affected 
by squamous cell carcinoma in the lips, inner 
aspect (C00.3-C00.9 codes of the International 
N2$++*3&$%* /"  !" Y*+,$+,+9" >Gth revision), tongue 
(C01-C02), oral cavity (C03-C06), or oropharynx 
(C09-C10), which  were subjected to primary 
surgery at the Hospital Heliópolis, between 
October 2006 and September 2007. This is a large 
hospital located in the city of São Paulo, Brazil, 
comprising a referral unit for H&N surgery. Being 
publicly sponsored, this hospital mostly offers 
free-of-charge treatment to low-income patients. 
A dental student (not pertaining to the hospital 
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inform their HRQOL status immediately before the 
primary surgery for tumor resection. The patients 
completed the University of Washington Quality of 
Life questionnaire (Portuguese version, UW-QOL, 
version 4) by themselves, without help of relatives 
or hospital staff.
This questionnaire has been specifically 
developed for the QOL assessment of patients 
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questions addressing relevant HRQOL dimensions 
for patients with oral and oropharyngeal cancer: 
pain, appearance, activity, recreation, swallowing, 
chewing, speech, shoulder function, taste, saliva 
production, mood, and anxiety. A Likert scale 
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indicating improved status17. The Portuguese 
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for the Brazilian context) was already validated15.
The initial, preoperative information on HRQOL 
of patients refers to the day of hospitalization for 
primary surgery for tumor resection. A dynamic 
search for each patient was performed at the 
>H4,$)"! 22 .H8(" !"+8)0,)4C"]$%*,/%+".,),"&2$++*3,#"
according to their status: deceased, dropout of the 
Sociodemographic characteristics Decease Survival  !?)7#$!',#@A'
(95%CI)(1)
p-value
Gender female   3   3 1.42 0.464
male 12 22 (0.56-3.60)
Age >54   7 12 0.97 0.936
<55   8 13 (0.43-2.18)
Skin color black   6   7 1.38 0.427
white   9 18 (0.62-3.09)
Education complete basic education   6   5 1.76 0.154
incomplete basic education   9 20 (0.81-3.81)
Behavior
Remained smoking   7 12 0.97 0.936
Never smoked/stopped smoking   8 13 (0.43-2.18)
Remained drinking alcoholic beverages   5   8 1.04 0.931
Never drank/stopped drinking 10 17 (0.44-2.44)
Clinical status
Tumor localization (2)  posterior sites   7   8 1.88 0.100
anterior sites   8 17 (0.89-3.99)
Tumor size (3) T3/T4   8   7 2.30 0.037
T1/T2   7 18 (1.05-5.04)
Regional metastasis N1/N2   8   5 2.18 0.030
N0   7 20 (1.09-5.17)
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cohort, or available for the evaluation of HRQOL 
evolution. Scores attributed to the overall status 
$/#"+(,&*3&"# '$*/+" !"ZM7TU".,),"*/#,(,/#,/%24"
assessed before and 1 year after surgery, being 
subsequently compared by a paired t-test.
J1*+"+%8#4"$2+ "8+,#"1 +(*%$2"32,+"0$%1,),#"X4"
the Clinical Genome of Cancer Project18 to inform 
socio-demographic characteristics (gender, age, 
skin color, and education), behavior (whether 
patients remained consuming tobacco and alcohol), 
and their clinical status (tumor localization and 
J\^"&2$++*3&$%* /<C"N -$)*$%,+".,),"#*&1 % ' 8+24"
classified for the assessment of survival. 
Sociodemographic characteristics used categories 
of gender (females/males), age (<55/>54), skin 
color (light- and dark-skinned blacks/whites), and 
education (complete/incomplete basic education, 
which, in Brazil corresponds to 8 years of formal 
schooling). Tumor localization differentiated 
/, (2$+'"$!!,&%*/0"$/%,)* )";2*(+9"-,+%*X82,"$/#"_  )"
of mouth, cheek mucosa, hard palate, gum and 
anterior two-thirds of the tongue) from posterior 
(base of tongue, soft palate, retromolar area, tonsil 
and oropharynx) portions of the stomatognathic 
+4+%,'C"J1,"J\^"&2$++*3&$%* /"$22 .,#"& '($)*/0"
patients with T1/T2 and T3/T4 tumors, and those 
with and without regional metastasis (N1-2/N0). 
Current smokers and alcohol consumers were 
compared with those that never smoked or drank, 
or interrupted the habit before hospitalization.
Sociodemographic, behavioral and clinical 
covariates instructed the comparative analysis of 
survival. This assessment used Poisson regression 
analysis with robust variance estimation2, which 
allowed calculating the relative risk of death 
$/#"%1,*)"),+(,&%*-,"E?F"& /3#,/&," */%,)-$2+C"`"
relative risk higher than the unity suggests that 
the comparison group had higher risk of death 
than the reference group. The inverse occurs when 
the relative risk is lower than the unity; whereas 
& /3#,/&,"*/%,)-$2+"*/&28#*/0"%1,"8/*%4"*/#*&$%,"%1$%"
survival did not differ between groups.
Statistical analyses used Stata 10 (Stata, Stata 
Corporation, College Station, Texas, United States 
of America), 2007. Patients signed a form of 
informed consent, and ethical approval was given by 
the Research Ethics Committees of the participating 
institutions (SISNEP N. 0078.0.264.017-05).
RESULTS
The use of the UW-QOL was well accepted by 
patients; they were cooperative, and no eligible 
participant refused to answer. The patients 
appreciated informing their HRQOL, and they 
completed the questionnaire without the help of 
relatives or any proxy respondent. During one full 
year of monitoring the H&N unit of the hospital, 53 
,2*0*X2,"($)%*&*($/%+".,),"*#,/%*3,#"! )"%1,"+%8#4="
that is, they had oral and oropharyngeal squamous 
cell carcinoma and were hospitalized for primary 
surgery. Two patients died during the immediate 
postoperative period, and four surgeries were 
cancelled for different reasons. The remaining 47 
patients were enrolled in the cohort: 19 patients 
1$#"%8' )"*/"%1," )$2"&$-*%4";_  )" !"' 8%19"0*/0*-$9"
retromolar area and palate), 12 in the oropharynx, 
11 in the tongue and 5 in the inner aspect of the 
lower lip.
One year after surgery, 7 patients (15%) could 
not be found and were considered dropout of the 
cohort. From the remaining patients, 15 (38%) 
1$#"#*,#"$/#"@?";a@F<"!82322,#"%1,"56H7TU"$0$*/C"
Socio-demographic and behavioral characteristics 
of patients did not associate with death, although 
covariates on clinical status did. Patients presenting 
HRQOL Domain Preoperatively 1-year follow-up Variation (%) 8#B*#6")*"!
Pain 76.0 85.0 +11.8 p=0.185
Appearance 86.0 77.0 –10.5 p=0.195
Activity 93.0 65.0 –30.1 p=0.002
Recreation 94.0 61.0 –35.1 p=0.003
Swallowing 92.0 64.6 –29.8 p=0.001
Chewing 74.0 34.0 –54.1 p<0.001
Speech 84.1 68.1 –19.1 p=0.003
Shoulder function 97.4 70.4 –27.7 p=0.001
Taste 86.6 82.8 –4.5 p=0.536
Saliva production 89.3 75.0 –16.0 p=0.006
Mood 73.0 68.0 –6.8 p=0.569
Anxiety 36.0 70.7 +96.3 p=0.007
Overall 81.8 68.5 –16.3 p=0.006
Table 2- !"#$%&' ()* +!,-./'012$32 4)5"$%'6 0*1)01*"#$71 "''1''51%# "%4 8/91"* ()::);/<0= :)%&$#<4$%": 7"*$"#$)% "%4 
p-values (paired t-test) (n=25)
C4(%D#$'().9,#+'.9%#E+4=#F# :4+,(#,<6@%3()*%#E<.3()4."#(4#!FF# .4#,<6@%3()*%#/%53)("
BIAZEVIC MGH, ANTUNES JLF, TOGNI J, ANDRADE FP, CARVALHO MB, WÜNSCH-FILHO V
2010;18(3):279-84
J Appl Oral Sci. 282
regional metastasis before surgery (relative risk 
B" @C>D=" E?F" & /3#,/&," */%,)-$2" B" >CGEH?C>:<"
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the 1-year follow-up of primary surgery (Table 1). A 
borderline excessive risk of death, at the threshold 
 !"+%$%*+%*&$2"+*0/*3&$/&,";(BGC>G<9".$+"*#,/%*3,#"
for patients with tumors at posterior anatomic 
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For survivors, chewing (48%), speech (44%), 
and anxiety (32%) were the most prevalent 
complaints at the baseline. Chewing (60%), 
swallowing (24%), and saliva production (20%) 
were the most relevant complaints at the 1-year 
follow-up (Figure 1).
Survivors presented a significantly reduced 
;(BGCGGa<"  -,)$22" )$%*/0"  !" ZM7TU" $%" >H4,$)"
follow-up, as compared with the preoperative 
$++,++',/%C"7TU"(),+,/%,#"+*0/*3&$/%24"),#8&,#"
ratings (p<0.05) for activity, recreation, chewing, 
swallowing, speech, shoulder function and saliva 
production. Chewing was the QOL domain with 
largest reduction of rating: from 74.0 preoperatively 
to 34.0 1 year after surgery. Anxiety was the 
poorest rating domain before surgery (36.0); 
however, anxiety was the only domain that 
*/&),$+,#"+*0/*3&$/%24"*%+"$-,)$0,")$%*/09"% ":GC:9">"
year after surgery (Table 2). The remaining HRQOL 




with the prognosis of death for patients subjected to 
primary surgery of oral and oropharyngeal cancer. 
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most relevant results of the study.
Survival analysis usually follows up patients for 
a longer period and assesses hazard ratios of the 
time lag between surgery and prospective death. 
This assessment was prevented by the short period 
of monitoring, and the reduced number of patients. 
Survival was exclusively assessed as a categorical 
outcome to appraise covariates for the risk of dying. 
Patients with regional metastasis and larger tumors 
1$#"$"1*01,)")*+A" !"#,$%1"#8)*/0"%1,"3)+%"4,$)"$!%,)"
surgery. Previous studies in the Brazilian context 
have also reported a lower survival rate for patients 
(),+,/%*/0"(  ),)"&2*/*&$2"() 32,4,9. No participant 
of the present study presented distant metastasis.
No sociodemographic characteristic was 
associated with survival. However, the study 
cannot be considered conclusive in this respect 
because of its reduced sample size. The comparison 
of outcomes reported by patients that continued 
consuming tobacco or alcoholic beverages with 
those that never smoked or drank, or interrupted 
the habit when affected by the disease, aimed 
at assessing the effectiveness of the patient’s 
support and commitment to the treatment. No 
differences in survival were observed among 
patients that remained smoking or drinking after 
surgery; anyhow, the number of patients currently 
monitored is too small to allow for inferences on 
this issue. There is little in the literature regarding 
the effect of tobacco on postoperative QOL status 
of patients with oral cancer; however, previous 
studies that assessed this condition reported absent 
association7,12.
Patients preparing for tumor resection have 
reasons to be anxious. They are affected by a life-
threatening disease, and forthcoming surgery may 
impact on their quality of life. Indeed, an average 
31.1% reduction in the overall HRQOL rating was 
reported for patients immediately after surgery3; 
that is, nearly one third of the patients’ remaining 
HRQOL, after disease had already subtracted part 
of their physical and psycho-social functioning. 
However, anxiety was the only domain that improved 
its rating in the longitudinal assessment, which 
suggests that survivors felt relieved and hopeful 
postoperatively. Most patients renew their state of 
mind after primary surgery, despite experiencing 
an immediate deterioration of HRQOL in several 
physiological domains. Patients with H&N cancer 
present high levels of depressive symptoms15; 
anxiety disorders usually rank highest at diagnosis, 
mental distress substantially decreases one to three 
years after surgery10,11.
Anxiety was the HRQOL domain ranking the 
poorest ratings preoperatively. In spite of this, 
complaints related to chewing and speech were 
even more prevalent than anxiety during the week 
that preceded hospitalization for tumor resection. 
Chewing was the domain ranking the poorest 
Figure 1- Prevalence of most important complaints for 
+!,-./'012$32 4)5"$%'6 0*1)01*"#$71 "''1''51%# "%4 
1-year follow-up (n=25)
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postoperative ratings; a larger reduction of ratings 
1 year after surgery affected chewing, activity, 
recreation and swallowing. A previous study in 
Brazil stated that, among physiological functions, 
chewing was the most prevalent complaint of 
patients with mouth neoplasms1. This observation 
reinforces the importance of dental rehabilitation 
to patients subjected to surgical resection of oral 
and oropharyngeal cancer.
There is little or no surprise at all to acknowledge 
that chewing is largely affected by surgical excision 
of mouth tissues. However, the large decrement 
of ratings attributed to this domain is suggestive 
that this cohort experienced a reduced access to 
specialized dental rehabilitation after surgery, which 
highlights the need of integrating the dentist to 
the multidisciplinary health care team that attends 
these patients.
Several studies described the postoperative 
evolution of HRQOL for patients with oral and 
oropharyngeal tumors and assessed factors 
associated with improvements in prognosis5-8,16,19. 
These studies reinforce the hypothesis that patients 
that survived surgery may effectively improve 
and even recover their HRQOL levels, at least to 
preoperative ratings. Therefore, the present report 
 !"#,&),$+,"*/"+,-,)$2"+(,&*3&"ZM7TU"# '$*/+"$!%,)"
surgery should be taken into careful consideration 
by medical staff in their effort to anticipate 
prognosis and design effective treatment protocols.
This study used the UW-QOL questionnaire to 
describe the postoperative evolution of HRQOL 
in patients with oral and oropharyngeal cancer. 
The UW-QOL is a validated, accurate, and 
internationally accepted survey instrument. Despite 
%1*+" X+,)-$%* /9"%1*+"R8,+%* //$*),".$+"+(,&*3&$224"
designed to assess impacts at the H&N region, and 
may be poorly comprehensive of broader clinical 
conditions.
The selection of patients exclusively considered 
only one hospital located in the city of São Paulo, 
and the sample cannot be considered representative 
of patients with oral and oropharyngeal cancer in 
any broader context. As this hospital is a referral 
health care unit for H&N surgery, some of their 
patients dwell outside the city of São Paulo, which 
may have contributed for the relatively large 
dropout of the cohort: 7 (15%) patients could not 
be contacted 1 year after surgery. Reduced sample 
size and the dropout are acknowledged as the main 
limitations of this study.
The small number of subjects also prevented 
the assessment of covariates for HRQOL ratings 
and evolution, which is also acknowledged as a 
limitation of this study. The outcomes for patients 
with H&N cancer who survive the initial period after 
diagnosis and surgery may be more dependent on 
their comorbidities than on their initial malignant 
tumor. It was also observe that individuals with 
poorer socioeconomic status may experience 
disproportionately higher HRQOL impacts from 
almost every disease and have poorer prognosis than 
their better-off counterparts. Having failed to assess 
factors associated with postoperative HRQOL, this 
study strongly advocates the conduction of further 
research involving a larger number of participants, 
to assess hypotheses of association, which may 
guide the adoption of preemptive interventions.
CONCLUSIONS
The prospective assessment of survival and QOL 
evolution is a useful adjunct for the assessment 
of prognosis and effectiveness of treatments. 
P8)-*-$2".$+"'$*/24"*/_8,/&,#"X4"%1,"&2*/*&$2"+%$%8+"
(regional metastasis and tumor size) of patients. 
P8)-*- )+"(),+,/%,#"+*0/*3&$/%"#,&),',/%"! )"%1,"
 -,)$22"$/#"+,-,)$2"# '$*/H+(,&*3&"7TU")$%*/0+"$%"
1-year follow-up. Chewing was the most relevant 
complaint of patients. The prospective monitoring 
of HRQOL may contribute to anticipate interventions 
aimed to improve survival and reduce the incidence 
of functional limitations in patients with oral and 
oropharyngeal cancer.
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